Cellular senescence and senolytics explained

What is a senescent cell?

A senescent cell is one that has permanently stopped dividing but resists dying. Normally a damaged or worn-out cell either repairs itself, divides, or is removed. A senescent cell does none of these cleanly — it lingers. That "stuck, won't leave" behaviour is why the nickname zombie cell stuck. A modest number of them is a normal part of biology; the problem is what happens as they build up.

The SASP: why zombie cells cause trouble

Senescent cells are not passive. They secrete a cocktail of inflammatory and tissue-remodelling signals known as the senescence-associated secretory phenotype, or SASP. Through the SASP, even a small population of senescent cells can promote chronic low-grade inflammation and nudge neighbouring healthy cells toward dysfunction. This is the core reason researchers care: it is not the cells sitting there, it is what they broadcast.

Why they accumulate with age

Two things shift over a lifetime. Cells keep entering senescence in response to stress and damage, while the immune system becomes less efficient at clearing the ones that form. The balance tips toward accumulation. This is why cellular senescence is counted among the hallmarks of aging — the influential framework that organises the biology of aging into a set of interacting processes.^[3] If you want the full map, our overview of the hallmarks of aging puts senescence in context with the others.

What senolytics aim to do

Senolytics are compounds designed to selectively push senescent cells into finally dying, so healthy tissue is less exposed to the SASP. In aged mice, clearing senescent cells improved physical function and increased lifespan.^[1] The first small human trial of a senolytic combination (dasatinib plus quercetin) reported a reduction in senescent-cell markers in patients.^[2] Read honestly, that is a proof of concept in people — a biomarker moved — not evidence of longer or healthier lives.

Human evidence still early

The honest bottom line

Cellular senescence is one of the better-understood reasons tissues age, and targeting it is a legitimate strategy rather than hype. But the human senolytic evidence is early, and the mouse results — however encouraging — do not automatically translate, which is the same skeptical standard we hold across the Rapamycin.store evidence desk. For the consumer compounds most discussed here, see our senolytics overview and the closer look at fisetin's benefits and evidence.

Frequently asked questions

What is a senescent cell?

A senescent cell is one that has permanently stopped dividing but resists dying. It lingers in tissue instead of being cleared, which is why it is often called a 'zombie' cell.

What is the SASP?

The SASP — senescence-associated secretory phenotype — is the mix of inflammatory and tissue-remodelling signals that senescent cells release. It is the main way a relatively small number of senescent cells can affect the healthy tissue around them.

Why do senescent cells build up with age?

Cells become senescent in response to stress and damage, and the immune system clears fewer of them as we get older. Over time the balance tips toward accumulation, which is why senescence is counted among the hallmarks of aging.

What do senolytics do?

Senolytics aim to selectively remove senescent cells so healthy tissue is less exposed to the SASP. In mice, clearing these cells improved physical function; the first small human trials have shown senolytics can reduce senescent-cell markers, but not yet that they extend healthy life.

Are senolytics proven in people?

Not yet. The human evidence is early — small, short trials measuring cellular markers rather than lifespan or hard health outcomes. The mouse evidence is stronger, but it does not automatically translate to humans.